Mammen Mathai
Insider CIK 1421050 · THRX SVP, Research & Early Clin Dev · TBPH SVP, Research & Early Clin Dev · TXG Director · JNJ EVP, Pharm, R&D
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TXG 10x Genomics, Inc. | A Award | 2024-06-11 | 2024-06-13 | 8,649 | — | $0 | 180,259 | SEC↗ |
| TXG 10x Genomics, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 4,661 | — | $0 | 4,661 | SEC↗ |
| TXG 10x Genomics, Inc. | A Award | 2023-06-14 | 2023-06-16 | 1,865 | — | $0 | 171,610 | SEC↗ |
| TXG 10x Genomics, Inc. | M Exercise deriv | 2023-05-11 | 2023-05-15 | 200,000 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | S Sale | 2023-05-11 | 2023-05-15 | 33,000 | $52.82 | $1.74M | 169,745 | SEC↗ |
| TXG 10x Genomics, Inc. | M Exercise | 2023-05-11 | 2023-05-15 | 200,000 | $1.16 | $232.0K | 202,745 | SEC↗ |
| TXG 10x Genomics, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 5,300 | — | $0 | 5,300 | SEC↗ |
| TXG 10x Genomics, Inc. | A Award | 2022-06-15 | 2022-06-17 | 2,120 | — | $0 | 2,745 | SEC↗ |
| JNJ JOHNSON & JOHNSON | M Exercise deriv | 2022-02-15 | 2022-02-17 | 7,740 | — | $0 | 737 | SEC↗ |
| JNJ JOHNSON & JOHNSON | F Tax w/h | 2022-02-15 | 2022-02-17 | 3,366 | $165.89 | $558.4K | 41,934 | SEC↗ |
| JNJ JOHNSON & JOHNSON | M Exercise | 2022-02-15 | 2022-02-17 | 7,740 | — | $0 | 45,300 | SEC↗ |
| JNJ JOHNSON & JOHNSON | M Exercise deriv | 2022-02-14 | 2022-02-15 | 7,418 | — | $0 | 0 | SEC↗ |
| JNJ JOHNSON & JOHNSON | A Award deriv | 2022-02-14 | 2022-02-17 | 38,736 | $165.89 | $6.43M | 38,736 | SEC↗ |
| JNJ JOHNSON & JOHNSON | A Award deriv | 2022-02-14 | 2022-02-17 | 3,922 | — | $0 | 3,922 | SEC↗ |
| JNJ JOHNSON & JOHNSON | M Exercise | 2022-02-14 | 2022-02-15 | 7,418 | — | $0 | 39,895 | SEC↗ |
| JNJ JOHNSON & JOHNSON | F Tax w/h | 2022-02-14 | 2022-02-15 | 2,335 | $168.85 | $394.3K | 37,560 | SEC↗ |
| TXG 10x Genomics, Inc. | A Award deriv | 2021-06-11 | 2021-06-15 | 1,563 | — | $0 | 1,563 | SEC↗ |
| TXG 10x Genomics, Inc. | A Award | 2021-06-11 | 2021-06-15 | 625 | — | $0 | 625 | SEC↗ |
| TXG 10x Genomics, Inc. | A Award deriv | 2020-06-15 | 2020-06-17 | 4,432 | — | $0 | 4,432 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other deriv | 2019-09-16 | 2019-09-16 | 200,000 | — | $0 | 200,000 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other deriv | 2019-09-16 | 2019-09-16 | 200,000 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2016-03-15 | 2016-03-17 | 90,000 | — | $0 | 288,111 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2016-02-20 | 2016-02-23 | 19,844 | $15.65 | $310.6K | 198,111 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2015-11-20 | 2015-11-24 | 934 | $17.17 | $16.0K | 217,955 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2015-08-20 | 2015-08-24 | 934 | $12.98 | $12.1K | 218,889 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2015-06-02 | 2015-06-04 | 7,360 | $13.83 | $101.8K | 219,823 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2015-05-20 | 2015-05-22 | 673 | $14.24 | $9.6K | 227,183 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2015-02-20 | 2015-02-24 | 674 | $19.52 | $13.2K | 227,856 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2015-02-05 | 2015-02-09 | 130,000 | — | $0 | 228,530 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2014-11-20 | 2014-11-24 | 658 | — | $0 | 80,492 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2014-10-08 | 2014-10-10 | 170,000 | — | $0 | 170,000 | SEC↗ |
| THRX THERAVANCE INC | F Tax w/h | 2014-08-20 | 2014-08-22 | 3,261 | $22.76 | $74.2K | 334,040 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2014-06-16 | 2014-06-18 | 28,365 | — | $0 | 337,301 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2014-06-02 | 2014-06-04 | 50,000 | — | $0 | 287,936 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2014-06-02 | 2014-06-04 | 21,000 | — | $0 | 308,936 | SEC↗ |
| THRX THERAVANCE INC | F Tax w/h | 2014-05-09 | 2014-05-12 | 22,833 | $26.86 | $613.3K | 239,136 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2014-04-27 | 2014-04-29 | 37,500 | — | $0 | 261,969 | SEC↗ |
| THRX THERAVANCE INC | G Gift | 2014-03-13 | 2014-05-12 | 1,200 | — | $0 | 237,936 | SEC↗ |
| THRX THERAVANCE INC | M Exercise deriv | 2014-03-06 | 2014-03-10 | 12,903 | — | $0 | 0 | SEC↗ |
| THRX THERAVANCE INC | M Exercise deriv | 2014-03-06 | 2014-03-10 | 29,250 | — | $0 | 0 | SEC↗ |
| THRX THERAVANCE INC | M Exercise | 2014-03-06 | 2014-03-10 | 12,903 | $12.40 | $160.0K | 195,219 | SEC↗ |
| THRX THERAVANCE INC | M Exercise | 2014-03-06 | 2014-03-10 | 29,250 | $16.00 | $468.0K | 224,469 | SEC↗ |
| THRX THERAVANCE INC | F Tax w/h | 2014-02-20 | 2014-02-24 | 4,307 | $39.98 | $172.2K | 182,316 | SEC↗ |
| THRX THERAVANCE INC | S Sale | 2014-02-14 | 2014-02-19 | 30,400 | $39.26 | $1.19M | 191,223 | SEC↗ |
| THRX THERAVANCE INC | S Sale | 2014-02-14 | 2014-02-19 | 4,600 | $40.04 | $184.2K | 186,623 | SEC↗ |
| THRX THERAVANCE INC | F Tax w/h | 2013-11-20 | 2013-11-22 | 4,569 | $36.40 | $166.3K | 222,073 | SEC↗ |
| THRX THERAVANCE INC | M Exercise deriv | 2013-08-21 | 2013-08-22 | 18,750 | — | $0 | 0 | SEC↗ |
| THRX THERAVANCE INC | M Exercise | 2013-08-21 | 2013-08-22 | 18,750 | $16.00 | $300.0K | 226,642 | SEC↗ |
| THRX THERAVANCE INC | F Tax w/h | 2013-08-20 | 2013-08-22 | 3,813 | $35.89 | $136.8K | 207,892 | SEC↗ |
| THRX THERAVANCE INC | S Sale | 2013-07-30 | 2013-08-01 | 7,000 | $36.51 | $255.6K | 211,705 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2013-07-24 | 2013-07-26 | 5,000 | — | $0 | 218,705 | SEC↗ |
| THRX THERAVANCE INC | M Exercise deriv | 2013-05-29 | 2013-05-31 | 6,451 | — | $0 | 0 | SEC↗ |
| THRX THERAVANCE INC | M Exercise deriv | 2013-05-29 | 2013-05-31 | 4,570 | — | $0 | 0 | SEC↗ |
| THRX THERAVANCE INC | M Exercise | 2013-05-29 | 2013-05-31 | 4,570 | $3.10 | $14.2K | 207,254 | SEC↗ |
| THRX THERAVANCE INC | M Exercise | 2013-05-29 | 2013-05-31 | 6,451 | $12.40 | $80.0K | 213,705 | SEC↗ |
| THRX THERAVANCE INC | F Tax w/h | 2013-05-20 | 2013-05-22 | 3,292 | $37.01 | $121.8K | 202,684 | SEC↗ |
| THRX THERAVANCE INC | S Sale | 2013-04-30 | 2013-05-02 | 6,800 | $33.72 | $229.3K | 206,176 | SEC↗ |
| THRX THERAVANCE INC | S Sale | 2013-04-30 | 2013-05-02 | 200 | $34.34 | $6.9K | 205,976 | SEC↗ |
| THRX THERAVANCE INC | F Tax w/h | 2013-02-20 | 2013-02-22 | 5,002 | $22.10 | $110.5K | 219,976 | SEC↗ |
| THRX THERAVANCE INC | S Sale | 2013-02-20 | 2013-02-22 | 7,000 | $22.14 | $155.0K | 212,976 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2013-02-07 | 2013-02-11 | 5,000 | — | $0 | 224,978 | SEC↗ |
| THRX THERAVANCE INC | M Exercise deriv | 2013-01-11 | 2013-01-14 | 2,655 | — | $0 | 0 | SEC↗ |
| THRX THERAVANCE INC | M Exercise deriv | 2013-01-11 | 2013-01-14 | 11,855 | — | $0 | 0 | SEC↗ |
| THRX THERAVANCE INC | M Exercise | 2013-01-11 | 2013-01-14 | 11,855 | $3.10 | $36.8K | 217,783 | SEC↗ |
| THRX THERAVANCE INC | M Exercise | 2013-01-11 | 2013-01-14 | 2,655 | $3.10 | $8.2K | 220,438 | SEC↗ |
| THRX THERAVANCE INC | G Gift | 2012-12-31 | 2013-01-14 | 460 | — | $0 | 219,978 | SEC↗ |
| THRX THERAVANCE INC | F Tax w/h | 2012-11-20 | 2012-11-20 | 4,874 | $21.08 | $102.7K | 205,928 | SEC↗ |
| THRX THERAVANCE INC | M Exercise deriv | 2012-11-14 | 2012-11-16 | 5,161 | — | $0 | 0 | SEC↗ |
| THRX THERAVANCE INC | M Exercise | 2012-11-14 | 2012-11-16 | 5,161 | $3.10 | $16.0K | 210,802 | SEC↗ |
| THRX THERAVANCE INC | S Sale | 2012-11-02 | 2012-11-06 | 6,800 | $21.42 | $145.7K | 205,841 | SEC↗ |
| THRX THERAVANCE INC | S Sale | 2012-11-02 | 2012-11-06 | 200 | $22.53 | $4.5K | 205,641 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2012-10-15 | 2012-10-17 | 5,000 | — | $0 | 212,641 | SEC↗ |
| THRX THERAVANCE INC | F Tax w/h | 2012-08-20 | 2012-08-22 | 4,644 | $27.01 | $125.4K | 207,641 | SEC↗ |
| THRX THERAVANCE INC | S Sale | 2012-08-13 | 2012-08-15 | 21,892 | $25.68 | $562.2K | 215,393 | SEC↗ |
| THRX THERAVANCE INC | S Sale | 2012-08-13 | 2012-08-15 | 3,108 | $26.15 | $81.3K | 212,285 | SEC↗ |
| THRX THERAVANCE INC | F Tax w/h | 2012-05-20 | 2012-05-22 | 3,832 | $20.33 | $77.9K | 237,285 | SEC↗ |
| THRX THERAVANCE INC | F Tax w/h | 2012-02-20 | 2012-02-22 | 9,747 | $18.54 | $180.7K | 241,117 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2012-02-15 | 2012-02-17 | 5,000 | — | $0 | 250,864 | SEC↗ |